Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 27, 2021 | Series A | $6.50M | 4 | Zepp | — | Detail |
Jan 1, 2021 | Seed | $1.30M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Zepp | Yes | Series A |
Krishna R. Bhupal | — | Series A |
Philip Dolan | — | Series A |
Shangbay Capital | — | Series A |